Introduction: Endometrial polyps are a common focal endometrial pathology, with abnormal uterine bleed ing (AUB) as a predominant symptom. Although the great majority of cases are benign, premalignancy or ma lignancy may develop within the polyp. The need for chronic immunosuppressive therapy in solid organ trans planted patients is associated with a significantly increased risk of malignant lesions.
Introduction
Endometrial polyps are a common focal endome trial pathology. The lesion can cause abnormal uterine bleedings (intermenstrual bleeding, heavy and pro longed menstrual bleeding), impede fertility or may re main asymptomatic. The incidence of polyps rises with age. Although the great majority of cases are benign, premalignancy or malignancy may develop within the polyp. The risk of malignancy is increased in women, especially menopausal women [1] , with abnormal uter ine bleedings and in lesions greater than 1015 mm [1, 2] . In the study of CostaPaiva et al., the frequency of premalignancy and malignancy in polyps was 1.6% and 2.5%, respectively, among patients with polyps associ ated with abnormal uterine bleedings [3] .
Patients after solid organ transplantation require chronic immunosuppressive therapy, which is known to be associated with an increased risk of premalignancy and malignancy [4] . Abnormal uterine bleedings occur more frequently in female solid organ recipients than in the general population and always need to be fol lowed by histopathological assessment of endometrial samples.
The aim of the study was to evaluate the incidence of endometrial polyps in patients after solid organ transplantation with abnormal uterine bleeding.
Material and methods
Medical files of women diagnosed with abnormal uterine bleeding at the 1 st Department of Obstetrics and Gynecology, Medical University of Warsaw in 1996 2008 were retrospectively analyzed. One hundred and five patients with abnormal uterine bleeding after solid organ transplantation were identified and included in the study group. A significant number of patients had recurrent AUB followed by two or even three diagnos tic procedures performed within the analyzed period of time. If the time between the procedures was more than one year, there could have been differences in the patient's weight, menopausal status, treatment and im munosuppressive regimen, thus the cases were count ed separately, which eventually gave the number of 125 cases. the study group and the control group are presented in Table I . The type of organ transplantation in the study group is shown in Figure 1 . Dilatation and curettage was performed in both groups followed by pathological evaluation of endometrial and cervical samples. Results were statistically analyzed.
Results
Endometrial polyps were the only pathological find ings in 15 cases (12%) from the study group and in 43 cases (21.5%) from the control group. Regarding the type of organ transplantation, polyps were diagnosed in 14 cases (11%) after renal transplantation versus 1 case (17%) after liver transplantation. In 21% (4 cases) of organ recipients with AUB there were endometrial hy perplasia and endometrial polyps as coexisting patholo gies. If cases of endometrial polyps coexisting with en dometrial hyperplasia were taken into account, the rate of endometrial polyps was compared to that observed in the general population (20% vs. 21.5%, respectively). In one case from the study group and in one case from the control group, endometrial polyp was associated with the coexisting endometrial cancer (Table II) .
Graft recipients with endometrial polyps were younger compared to patients from the control group (46.36 SD 9.87 vs. 54.25 SD 9.07 years). Coexisting mor bidities, including hypertension and diabetes mellitus, were observed more frequently among graft recipients (78.6% vs. 44.2% and 35.7% vs. 4.6% of cases, respec tively). The evaluation of risk with the use of a logistic regression model showed that the age > 45 years and pregnancy in obstetrical history were associated with a decreased risk of endometrial polyps (OR 0.448, CI: 0.2001.005 and OR 0.504, CI: 0.2501.018).
Discussion
The growing number of organ transplantations across the world as a generally accepted form of treat ment of endstage organ failure is followed by the growing number of recipients treated with immunosup pressive agents. Many studies indicate the increased rate of certain types of tumors among patients after solid organ transplantation [57] . Neoplasm is one of the leading causes of death in this group of patients. Renal recipients, the most numerous subgroup of trans plant patients, are observed to have a 3 times higher risk of 25 types of tumors [8] . The exact mechanisms of carcinogenesis among organ recipients are not clear. Viral infections [9, 10] and chronic immunosuppression, which impair antitumour protective mechanisms [11, 12] are believed to be the leading causes of malignancy. Other factors that may play a role are UVA and UVB radiation [13] and less known mechanisms.
Women after organ transplantation form a specif ic group of patients. Higher levels of estrogens with normal levels of gonadotropins [14] and lower levels of progesterone in the luteal phase of the menstrual cycle have been reported in female graft recipients. Higher levels of estrogen are likely to be related to the impaired metabolism of steroid hormones [15] . Due to multidrug therapy, including chronic immunosuppres sion as well as higher vulnerability to viral infections and secondary morbidities, those patients have a high er risk of neoplasm [1619] . Female allograft recipients frequently present with abnormal uterine bleedings that concern both the patient and the gynecologist. Given the increased risk of neoplasms, the presence of disturbing symptoms such as AUB has to be followed with careful diagnostic procedures with endometrial sampling. metrial polyps coexisting with endometrial hyperplasia were taken into account, the rate of endometrial polyps was similar to that observed in the general population (20% vs. 21.5%, respectively). A high rate of endometri al hyperplasia has been already observed among female allograft recipients, what is believed to be associated with inappropriate estrogen stimulation of endometrial tissue and chronic immunosuppressive therapy.
In conclusion, chronic immunosuppression, asso ciated with an increased risk of malignancy, does not increase the risk of endometrial polyps among female graft recipients. In the case of abnormal uterine bleed ings in women after organ transplantation, dilatation and curettage can serve as a primary diagnostic meth od of endometrial sampling.
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Endometrial polyp is one of pathological lesions as sociated with abnormal uterine bleedings. Etiology of endometrial polyps is complex. Hormonal abnormalities, especially related to coexisting obesity and hypertension [20] , improper angiotensin and progesterone receptor expression [21, 22] , certain drugs (tamoxifen, angioten sin convertase inhibitors etc.) [23, 24] and genetic fac tors are taken into consideration. Polyps might be a soli tary or multiple lesion, with a peduncular or based shape. The sizes of endometrial polyps vary from millimeters to centimeters and the larger sizes of polyps are believed to be associated with a higher risk of malignancy [2, 3] .
Suspicion of the endometrial polyp is based on so nographic examination. The polyp on transvaginal so nography is imaged as a hyperechoic lesion surrounded by a hypoechoic endometrial layer or as a nonspecific thickness of endometrial mucosa. Sensitivity of imag ing might be elevated on threedimensional or saline infusion sonography [25] or when power Doppler dis plays a single blood vessel supplying the focal lesion [26] . Verification of sonographic findings is possible during hysteroscopy, considered as the most sensi tive method of endometrial polyp detection [27] . This method, especially its office modification of Bettocchi, has become more frequently used in female allograft recipients. However other conservative methods of en dometrial sampling, mainly dilatation and curettage, are still common.
In our study, endometrial polyp as a single cause of abnormal uterine bleeding was found less frequently among women after solid organ transplantation com pared to the control group. However, if cases of endo 
